A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin

Pediatrics. 2004 Jan;113(1 Pt 1):119-23. doi: 10.1542/peds.113.1.119.

Author

Attallah Kappas¹

Affiliation

¹ Rockefeller University Hospital, New York, New York, USA. kappas@rockefeller.edu

PMID: 14702459
DOI: 10.1542/peds.113.1.119

No abstract available

Publication types

Comparative Study
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Bilirubin / biosynthesis*
Enzyme Inhibitors / therapeutic use*
Female
Heme Oxygenase (Decyclizing) / antagonists & inhibitors*
Humans
Infant, Newborn
Jaundice, Neonatal / drug therapy*
Jaundice, Neonatal / therapy
Metalloporphyrins / therapeutic use*
Phototherapy
Randomized Controlled Trials as Topic

Substances

Enzyme Inhibitors
Metalloporphyrins
tin mesoporphyrin
Heme Oxygenase (Decyclizing)
Bilirubin